01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
(1) Custom enzyme formulations and probiotic compositions, namely, enzyme preparations and probiotic compositions for use in the manufacture of animal feed not for veterinary purposes.
4.
Bacillus velezensis compositions and methods of use thereof
BacillusBacillus velezensisBacillus velezensis strain identified as BV379 is provided. Compositions comprising BV379 and methods of using the same are also provided.
Novel fungal enzyme compositions, and more particularly, enzyme mixtures comprising a plurality of fungal enzymes (e.g., from Aspergillus and Candida) are provided. The disclosure further relates to dietary supplements, foods and beverages containing these enzyme mixtures, and methods of making and using the same.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Custom enzyme formulations, namely, enzyme preparations for use in animal feed not for veterinary purposes and enzyme preparations for use in the food and beverage, dietary supplements, industrial cleaning and waste, septic and drain, and aquaculture industries
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Custom enzyme formulations, namely, enzyme preparations for use in animal feed not for veterinary purposes and enzyme preparations for use in the food and beverage, dietary supplements, industrial cleaning and waste, septic and drain, and aquaculture industries
Fungal protease compositions, and more particularly, proteolytic enzyme mixtures comprising a plurality of Aspergillus proteases are provided. The disclosure also relates to protein hydrolysates, food and beverage products and dietary supplements produced using these proteolytic enzyme mixtures, and methods of making and using the same.
BacillusBacillus species, and more particularly, a Bacillus subtilis strain identified as BS50 is provided. Compositions comprising the BS50 strain, methods of making products comprising the same, and methods of using the same are also provided.
AspergillusCandidaCandida) are provided. The disclosure further relates to dietary supplements, foods and beverages containing these enzyme mixtures, and methods of making and using the same.
Novel fungal enzyme compositions, and more particularly, enzyme mixtures comprising a plurality of fungal enzymes (e.g., from Aspergillus and Candida) are provided. The disclosure further relates to dietary supplements, foods and beverages containing these enzyme mixtures, and methods of making and using the same.
Fungal protease compositions, and more particularly, proteolytic enzyme mixtures comprising a plurality of Aspergillus proteases are provided. The disclosure also relates to protein hydrolysates, food and beverage products and dietary supplements produced using these proteolytic enzyme mixtures, and methods of making and using the same.
Aspergillus Aspergillus proteases are provided. The disclosure also relates to protein hydrolysates, food and beverage products and dietary supplements produced using these proteolytic enzyme mixtures, and methods of making and using the same.
40 - Treatment of materials; recycling, air and water treatment,
42 - Scientific, technological and industrial services, research and design
45 - Legal and security services; personal services for individuals.
Goods & Services
Custom manufacture of enzymes for others; custom blending of enzymes for others Custom formulation, namely, custom development of enzyme technologies; research and development of enzyme technologies Regulatory compliance consulting in the field of enzyme technologies
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Custom enzyme formulations and probiotic compositions, namely, enzyme preparations and probiotic compositions for use in the manufacture of animal feed not for veterinary purposes
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Custom enzyme formulations, namely, enzyme preparations for use in animal feed not for veterinary purposes and the food and beverage, industrial cleaning and waste, septic and drain, and aquaculture industries
40 - Treatment of materials; recycling, air and water treatment,
42 - Scientific, technological and industrial services, research and design
45 - Legal and security services; personal services for individuals.
Goods & Services
Custom manufacture of enzymes and microbes for others; custom blending of enzymes and microbes for others Custom formulation, namely, custom development of enzyme and microbial technologies; research and development of enzyme and microbial technologies Regulatory compliance consulting in the field of enzyme and microbial technologies
40 - Treatment of materials; recycling, air and water treatment,
42 - Scientific, technological and industrial services, research and design
45 - Legal and security services; personal services for individuals.
Goods & Services
Custom manufacture of enzymes and microbes for others; custom blending of enzymes and microbes for others Custom formulation, namely, custom development of enzyme and microbial technologies; research and development of enzyme and microbial technologies Regulatory compliance consulting in the field of enzyme and microbial technologies
Bacillus subtilis strain identified as MB40 is provided. Compositions comprising the MB40 strain, methods of making products comprising the same, and methods of using the same are also provided.
A23G 9/36 - Frozen sweets, e.g. ice confectionery, ice-creamMixtures therefor characterised by the composition containing microorganisms or enzymesFrozen sweets, e.g. ice confectionery, ice-creamMixtures therefor characterised by the composition containing paramedical or dietetical agents, e.g. vitamins
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Novel combinations of Bacillus strains are provided, including combinations suitable for bioremediation of contaminants. The disclosure also relates to compositions comprising the novel combinations of Bacillus strains and methods of using the same to bioremediate contaminated sites.
Bacillus subtilis strain identified as MB40 is provided. Compositions comprising the MB40 strain, methods of making products comprising the same, and methods of using the same are also provided.
A23G 9/36 - Frozen sweets, e.g. ice confectionery, ice-creamMixtures therefor characterised by the composition containing microorganisms or enzymesFrozen sweets, e.g. ice confectionery, ice-creamMixtures therefor characterised by the composition containing paramedical or dietetical agents, e.g. vitamins
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
A spore-forming Bacillus species, and more particularly, a Bacillus subtilis strain identified as MB40 is provided. Compositions comprising the MB40 strain, methods of making products comprising the same, and methods of using the same are also provided.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Custom enzyme formulations, namely, enzyme preparations for use in animal feed not for veterinary purposes and the food and beverage, industrial cleaning and waste, septic and drain, and aquaculture industries
39.
Bacillus strains and methods of use to suppress the activities and growth of fungal plant pathogens
A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
C12Q 1/18 - Testing for antimicrobial activity of a material
This invention provides compositions of Bacillus strains and methods for using such compositions to inhibit the activity and/or growth of fungal pathogens of plants. In one embodiment, this invention provides a composition comprising Bacillus bacteria selected from the group consisting of Brevibacillus laterosporus strain CM-3, Brevibacillus laterosporus strain CM-33, Bacillus amyloliquefaciens BCM-CM5, Bacillus licheniformis ATCC-11946, Bacillus mojavensis BCM-01, Bacillus pumilus NRRL-1875, Bacillus subtilis 10 DSM-10, Bacillus subtilis NRRL-1650, Bacillus megaterium BCM-07, Paenibacillus polymyxa DSM-36, Paenibacillus chitinolyticus DSM-11030, and combinations thereof. In another embodiment, this invention provides a method for preparing a bacterial composition comprising one or more Bacillus strains by growing Bacillus strain bacteria until the bacteria form spores, collecting said spores, and formulating said composition.
A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
42.
Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
A61K 38/54 - Mixtures of enzymes or proenzymes covered by more than a single one of groups or
A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
46.
Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
Candida cylindracea, alone or in combination with amylase or amyloglucosidase, protease and/or lactase. Furthermore, the invention discloses methods for treating pancreatic enzyme insufficiency comprising administering compositions to patients in need thereof.
A61K 38/54 - Mixtures of enzymes or proenzymes covered by more than a single one of groups or
47.
A COMPOSITION WITH A FUNGAL (YEAST) LIPASE AND METHOD FOR TREATING LIPID MALABSORPTION IN CYSTIC FIBROUS AS WELL AS PEOPLE SUFFERING FROM PANCREATIC LIPASE INSUFFICIENCY
The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from Candida cylindracea, alone or in combination with amylase or amyloglucosidase, protease and/or lactase. Furthermore, the invention discloses methods for treating pancreatic enzyme insufficiency comprising administering compositions to patients in need thereof.
G01N 33/554 - ImmunoassayBiospecific binding assayMaterials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof